SUPEROxIDE DISMUTASE AS A COMPONENT OF ANTIOxIDANT THERAPY: CURRENT STATE OF THE ISSUE AND PROSPECTS. A LITERATURE REVIEW
Abstract
Oxidative stress, developing in many diseases, is an imbalance between pro-oxidants and antioxidant defense mechanisms of the body. Antioxidant enzymes such as superoxide dismutase (SOD) play a key role in reduction of oxidative stress in vivo. Thus, a decrease in formation of reactive oxygen species (ROS), as well as activation of lipid peroxidation (LPO) due to exogenous SOD intake could be an effective method of prevention and treatment of some diseases. In this paper, we provide an overview of the results of experimental and clinical studies on the use of intravenous drugs and dietary supplements, containing SOD, in the treatment of inflammatory, infectious, cardiovascular and neurodegenerative diseases. As a result of SOD administration, the majority of authors observed an increase in the content of endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase), i.e., stimulation of endogenous antioxidant defence and consequent reduction of oxidative stress, which may explain mechanisms of positive effects observed.
About the Authors
T. A. Pushkina
Federal Medical and biophysical Center n.a. A.I. burnazyan
Russian Federation
Russian Federation
Teaching Assistant at the Department of Rehabilitation and Resort Medicine with Nursing Care,
Moscow
E. S. Tokayev
OOO (LLC) Academia-T
Russian Federation
Moscow
Russian Federation
Moscow
T. S. Popova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
E. N. Borodina
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Davies K.J. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp. 1995;61:1–31.
2. Heilbronn L., Smith S.R., Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord. 2004;28 Suppl 4:S12–S21.
3. Ozata M., Mergen M., Oktenli C., et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627–631.
4. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010;49(11):1603–1616.
5. Keaney J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. arterioscler Thromb Vasc Biol. 2003;23(3):434–439.
6. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987;1(5):358–364.
7. Olusi S.O. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord. 2002;26(9):1159–1164.
8. Shanin Yu.N., Shanin V.Yu., Zinov’ev E.V. Antioxidant therapy in clinical practice. Saint Petersburg: ELBI-SPb Publ., 2003. 128 p. (In Russian).
9. Carillon J., Fouret G., Feillet-Coudray C., et al. Short-term assessment of toxicological aspects, oxidative and inflammatory response to dietary melon superoxide dismutase in rats. Food Chem Tox. 2013;55:323–328.
10. Feillet-Coudray C., Sutra T., Fouret G., et al. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med. 2009;46(5):624–632.
11. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761.
12. Muchova J., Sustrova M., Garaiova I., et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of down syndrome patients. Free Radic Biol Med. 2001;31(4):499–508.
13. Nakajima S., Ohsawa I., Nagata K., et al. Oral supplementation with melon superoxide dismutase extract promotes antioxidant defences in the brain and prevents stress-induced impairment of spatial memory. Behav Brain Res. 2009;200(1):15–21.
14. Pincemail J., Bonjean K., Cayeux K., Defraigne J.-O. Physiological action of antioxidant defences. Nutr Clin Metabol. 2002;16:233–239.
15. Scandalios J.G. Molecular genetics of superoxide dismutase in plants. In: Scandalios J.G., ed. Oxidative stress and molecular biology of antioxidant defences. New York: Cold Spring Harbor Laboratory Press, 1997. 527–568.
16. McCord J.M. The evolution of free radicals and oxidative stress. Am J Med. 2000;108(8):652–659.
17. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem.
18. 1995;64:97–112.
19. Beyer W., Imlay J., Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol. 1991;40:221–253.
20. Baret A., Jadot G., Michelson A.M. Pharmacokinetics and anti-inflammatory properties in the rat of superoxide dismutase (CuSODs and MnSOD) from various species. Biochem Pharmacol. 1984;33(17):2755–2760.
21. Clarke M.B., Wright R., Irwin D., et al. Sustained lung activity of a novel chimeric protein, SOD2/3, after intratracheal administration. Free Radic Biol Med. 2010;49(12):2032–2039.
22. Chan K., Kan Y.W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA. 1999;96(22):12731–12736.
23. Assa’ad A.H., Ballard E.T., Sebastian K.D., et al. Effect of superoxide dismutase on a rabbit model of chronic allergic asthma. Ann Allergy Asthma Immunol. 1998;80(3):215–224.
24. Tanaka K., Tanaka Y., Miyazaki Y., et al. Therapeutic effect of lecithinized superoxide dismutase on pulmonary emphysema. J Pharmacol Exp Ther. 2011;338(3):810–818.
25. Laursen J.B., Rajagopalan S., Galis Z., et al. Role of superoxide in angiotensin IIinduced but not catecholamine-induced hypertension. Circulation. 1997;95(3):588–593.
26. Wengenack T.M., Curran G.L., Poduslo J.F. Postischemic, systemic administration of polyamine modified superoxide dismutase reduced hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res. 1997;754(1–2):46–54.
27. Gammer W., Broback L.G. Clinical comparison of orgotein and methylprednisolone acetate in the treatment of osteoarthrosis of the knee joint. Scand J Rheumatol. 1984;13(2):108–112.
28. Talke M. Intra-articular therapy with superoxide dismutase (orgotein) or cortisone in rheumatoid and arthritic inflammatory finger joint lesions. Handchir Mikrochir Plast Chir. 1984;16(1):59–63.
29. McIlwain H., Silverfield J.C., Cheatum D.E., et al. Intra-articular orgotein in osteoarthritis of the knee : a placebo-controlled efficacy, safety, and dosage comparison. Am J Med. 1989;87(3):295–300.
30. Vozenin-Brotons M.C., Sivan V., Gault N., et al. Antifibrotic action of Cu/Zn SOD is mediated by TGF-”1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med. 2001;30(1):30–42.
31. Edeas M.A., Emerit I., Khalfoun Y., et al. Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro:inhibition by superoxide dismutase. Free Radic Biol Med. 1997;23(4):571–578.
32. Takehara Y., Yamaoka K., Sato E.F., et al. DNA damage by various forms of active oxygens and its inhibition by different scavengers using plasmid DNA. Physiol Chem Phy Med. 1994;26(3):215–226.
33. Carillon J., Rugale C., Rouanet J.M., et al. Endogenous antioxidant defense induction by melon superoxide dismutase reduces cardiac hypertrophy in spontaneously hypertensive rats. Int J Food Sci Nutr. 2014;65(5):602–609.
34. Décordé K., Ventura E., Lacan D., et al. A SOD rich melon extract ExtramelO prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis. Nutr Metab Cardiovasc Dis. 2010;20(5):301–307.
35. Lacan D., Baccou J.C. High levels of antioxidant enzymes correlate with delayed senescence in nonnetted muskmelon fruits. Planta. 1998;204(3): 377–382.
36. Perez-Carreras M., Del Hoyo P., Martin M.A., et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology. 2003;38(4):999–1007.
37. Jadot G. Anti-inflammatory activity of superoxide dismutases studies on adjuvant induced polyarthritis in rats. Free Rad Res Comms. 1985;2(2):27–42.
38. Regnault C., Roch-Arveiller M., Tissot M., et al. Effect of encapsulation on the anti-inflammatory properties of superoxide dismutase after oral administration. Clin Chim Acta. 1995;240(2):117–127.
39. Webb C.B., Lehman T.L., McCord K.W. Effects of an oral superoxide dismutase enzyme supplementation on indices of oxidative stress, proviral load, and CD4:CD8 ratios in asymptomatic FIVinfected cats. J Feline Med Surg. 2008;10(5):423–430.
40. Milesi M.A., Lacan D., Brosse H., et al. Effect of an oral supplementation with a proprietary melon juice concentrate (Extramel®) on stress and fatigue in healthy people: a pilot, double-blind, placebo-controlled clinical trial. Nutr J. 2009;8:40.
41. Esco R., Valencia J., Coronel P.; et al. Efficacy of orgotein in prevention of late side effects of pelvic irradiation : a randomized study. Int J Radiat Oncol Biol Phys. 2004;60(4):1211–1219.
42. Dugas B. Glisodin®: A nutraceutical product that promote the oral delivery of superoxide dismutase. Free Radic Biol Med. 2002;33:S64.
43. Décordé K., Teissedre P.L., Sutra T., et al. Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res. 2009;53(5):659–666.
44. Vaille A., Jadot G., Elizagaray A. Anti-inflammatory activity of various superoxide dismutases on polyarthritis in the Lewis rat. Biochem Pharmacol. 1990;39(2):247–255.
45. Vouldoukis I., Lacan D., Kamate C., et al. Antioxidant and anti-inflammatory properties of a Cucumis melo LC extract rich in superoxide dismutase activity. J Ethnopharmacol. 2004;94(1):67–75.
46. Arangoa M.A., Campanero M.A., Renedo M.J., et al. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm Res. 2001;18(11):1521–1527.
47. Lund-Olesen K., Menander-Huber K.B. Intra-articular orgotein therapy in osteoarthritis of the knee. A double-blind, placebo-controlled trial. Arzneimittelforschung. 1983; 33(8):1199–1203.
48. Antonic V., Rabbani Z.N., Jackson I.L., Vujaskovic Z. Subcutaneous administration of bovine superoxide dismutase protects lungs from radiation induced lung injury. Free Radic Res. 2015;49(10):1259–1268.
49. Sorescu D., Griendling K.K. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail. 2002;8(3):132–140.
50. Lallès J.P., Bosi P., Smidt H., Stokes C.R. Nutritional management of gut health in pigs around weaning. Proc Nutr Soc. 2007;66(2):260–268.
51. Okada F., Shionoya H., Kobayashi M., et al. Prevention of inflammationmediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. Brit J Cancer. 2006;94(6):854–862.
52. Vouldoukis I., Conti M., Krauss P.,et al. Supplementation with Gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress. Phytother Res. 2004;18(12):957–962.
53. Lalles J.P., Lacan D., David J.C. A melon pulp concentrate rich in superoxide dismutase reduces stress proteins along the gastrointestinal tract of pigs. Nutrition. 2011;27(3):358–363.
54. Rosenfeld W.N., Davis J.M., Parton L., et al. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1996;97(6 Pt1):811–817.
55. Nelson S.K., Bose S.K., Grunwald G.K., et al. The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy. Free Radic Biol Med. 2006;40(2):341–347.
56. Skarpanska-Stejnborn A., Pilaczynska-Szczesniak L., Basta P., et al. Effects of oral supplementation with plant superoxide dismutase extract on selected redox parameters and an inflammatory marker in a 2,000-m rowing-ergometer test. Int J Sport Nutr Exerc Metab. 2011;21(2):124–134.
57. Izumi M., McDonald M.C., Sharpe M.A., et al. Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock. 2002;18(3):230–235.
58. Gonzalez P.K., Zhuang J., Doctrow S.R., et al. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther. 1995;275(2):798–806.
59. Juurlink B.H. Dietary Nrf2 activators inhibit atherogenic processes. Atherosclerosis. 2012;225(1):29–33.
60. Negi G., Kumar A., Joshi R.P., Sharma S.S. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun. 2011;408:1–5.
61. Pedruzzi L.M., Stockler-Pinto M.B., Leite M.J., Mafra D. Nrf2-keap1 system versus NF-kB: The good and the evil in chronic kidney disease? Biochimie. 2012;94(12):2461–2466.
Review
For citations:
Pushkina T.A., Tokayev E.S., Popova T.S., Borodina E.N. SUPEROxIDE DISMUTASE AS A COMPONENT OF ANTIOxIDANT THERAPY: CURRENT STATE OF THE ISSUE AND PROSPECTS. A LITERATURE REVIEW. Russian Sklifosovsky Journal "Emergency Medical Care". 2016;(4):42-47. (In Russ.)
Views:
1951
Email this article 